Skip to main content

Table 3 Clinical data of patients with VUS

From: Prevalence of TECTA mutation in patients with mid-frequency sensorineural hearing loss

Family

Genotypes

Case

Age of diagnosis

Age at the latest Examination

Audiometric

configuration

Hearing lossSeveritya

Progressionb

Vestibularsymptoms

Inheritance patternc

5

p.[L940I];[=]

II-1

40 y

81 y

High-Frequency

Moderate

Unknown

Absent

AD

III-1

40 y

47 y

Shallow U-shaped

Moderate

Unknown

Absent

III-2

33 y

44 y

High-Frequency

Mild

Unknown

Present

6

p.[R1033Q];[=]

II-1

46 y

57 y

Shallow U-shaped

Moderate

Unknown

Absent

AD

7

p.[L1439I];[=]

III-1

6 y

16 y

Shallow U-shaped

Moderate

Stable

Absent

AD

8

p.[L1439I];[=]

III-1

16 y

38 y

U-shaped

Mild

Stable

Absent

AD

9

p.[V1646 M];[=]

III-1

8 y

23 y

Unknown

Moderate

Unknown

Unknown

AD

III-3

3 y

21 y

Shallow U-shaped

Moderate

Stable

Absent

10

p.[P1791R];[=]

III-2

6y

13 y

Shallow U-shaped

Mild

Unknown

Absent

AD

  1. AD autosomal dominant; AR autosomal recessive
  2. aMild, 20–40 dB HL; moderate, 41–70 dB HL; severe, 71–95 dB HL; profound, >95 dB HL (better hearing ear, averaged over 0.5, 1, 2, and 4 kHz)
  3. bProgressive, deterioration of >15 dB HL in the average over the frequencies of 0.5, 1, and 2 kHz within a 10-year period
  4. cInheritance pattern estimated from genotypes and phenotypes of family members